Juliana Viegas graduated in Pharmacy at Federal University of Ouro Preto (2016), Brazil, where she worked as a treinee researcher in a governmental program: Programa de Educação Tutorial - PET SESu/MEC. During her graduation she developed Liposomes, in which generated a pharmaceutical patent (BR BR10201701340). Before the Master, she worked in pharmaceutical industry – Fundação Ezequiel Dias (FUNED) (2016) in the field of Physical Chemical Quality Control, focusing on validation of analytical methods, in which improve her qualifications in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography, Franz cell.
She obtained a MSc (2019) and PhD degree (2022) from University of São Paulo, School of Pharmaceutical Sciences of Ribeirão Preto (FAPESP Fellow). The main field of study was nanotechnology, aiming the establishment of multifunctional lipid-based nanoparticles for co-delivery of chemotherapeutics and siRNAs to treat skin cancer. During these 5 years she improve her knowledge in the development and characterization of nanostructured systems and skin diseases, highlighting skin cancer.
Overall, she published 15 articles in peer-reviewed indexed journals and so far, have an h-index 8, total number of citations of 268. She also wrote 2 book’s chapters and 1 pharmaceutical patent.
She was a member of the Scientific Committee of the Student Chapter of the American Association Pharmaceutical Scientists (AAPS) on the biennium 2017-2018.
In addition, she performed pedagogical training in the Programa de Aperfeiçoamento de Ensino (PAE) in Pharmaceutical Nanotechnology (2018) and Pharmacotechnics (2020).
She is a Post-doctoral fellow since 2022 at NTDD group at i3S.
Selected Publications
Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening. Advanced Science:, 2024. [Journal: Article] [IF: 14.3 (*)]
DOI: 10.1002/advs.202408707 SCOPUS: 85207629059
Viegas J., Sarmento B.
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research. Advanced Drug Delivery Reviews208:, 2024. [Journal: Review] [CI: 11] [IF: 15.2 (*)]
DOI: 10.1016/j.addr.2024.115295 SCOPUS: 85188803871
Viegas J.S.R., Araujo J.S., Leite M.N., Praça F.G., Ciampo J.O.D., Espreáfico E.M., Frade M.A.C., Bentley M.V.L.B.
Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies. Drug Delivery and Translational Research:, 2024. [Journal: Article] [IF: 5.7 (*)]
DOI: 10.1007/s13346-024-01692-w SCOPUS: 85202926665
Costa S., Rodrigues J., Vieira C., Dias S., Viegas J., Castro F., Sarmento B., Leite Pereira C.
Advancing osteosarcoma 3D modeling in vitro for novel tumor microenvironment-targeted therapies development. Journal of Controlled Release376:1068-1085, 2024. [Journal: Article] [IF: 10.5 (*)]
DOI: 10.1016/j.jconrel.2024.10.068 SCOPUS: 85208199433
Viegas J., Dias S., Carvalho A.M., Sarmento B.
Characterization of a human lesioned-skin model to assess the influence of skin integrity on drug permeability. Biomedicine and Pharmacotherapy169:, 2023. [Journal: Article] [CI: 5] [IF: 6.9]
DOI: 10.1016/j.biopha.2023.115841 SCOPUS: 85178191998
Viegas J.S.R., Bentley M.V.L.B., Vicentini F.T.M.d.C.
Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology78:, 2022. [Journal: Review] [CI: 5] [IF: 5]
DOI: 10.1016/j.jddst.2022.103964 SCOPUS: 85141973728
Tavares Luiz M., Santos Rosa Viegas J., Palma Abriata J., Viegas F., Testa Moura de Carvalho Vicentini F., Lopes Badra Bentley M.V., Chorilli M., Maldonado Marchetti J., Tapia-Blácido D.R.
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics165:127-148, 2021. [Journal: Article] [CI: 84] [IF: 5,6]
DOI: 10.1016/j.ejpb.2021.05.011 SCOPUS: 85108303638
Leite M.N., Viegas J.S.R., Praça F.S.G., de Paula N.A., Ramalho L.N.Z., Bentley M.V.L.B., Frade M.A.C.
Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug Dacarbazine. European Journal of Pharmaceutical Sciences160:, 2021. [Journal: Article] [CI: 14] [IF: 5,1]
DOI: 10.1016/j.ejps.2021.105769 SCOPUS: 85101399208
Borgheti-Cardoso L.N., Viegas J.S.R., Silvestrini A.V.P., Caron A.L., Praça F.G., Kravicz M., Bentley M.V.L.B.
Nanotechnology approaches in the current therapy of skin cancer. Advanced Drug Delivery Reviews153:109-136, 2020. [Journal: Review] [CI: 80] [IF: 15,5]
DOI: 10.1016/j.addr.2020.02.005 SCOPUS: 85082647853
Viegas J.S.R., Praça F.G., Caron A.L., Suzuki I., Silvestrini A.V.P., Medina W.S.G., Del Ciampo J.O., Kravicz M., Bentley M.V.L.B.
Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Delivery and Translational Research10(3):646-660, 2020. [Journal: Article] [CI: 65] [IF: 4,6]
DOI: 10.1007/s13346-020-00723-6 SCOPUS: 85079715734
Barros A.S., Pinto S., Viegas J., Martins C., Almeida H., Alves I., Pinho S., Nunes R., Harris A., Sarmento B.
Orally Delivered Stimulus-Sensitive Nanomedicine to Harness Teduglutide Efficacy in Inflammatory Bowel Disease. Small20(45):, 2024. [Journal: Article] [IF: 13 (*)]
DOI: 10.1002/smll.202402502 SCOPUS: 85198399661
Pinto S., Viegas J., Cristelo C., Pacheco C., Barros S., Buckley S.T., Garousi J., Gräslund T., Santos H.A., Sarmento B.
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model. ACS Nano18(41):28406-28424, 2024. [Journal: Article] [IF: 15.8 (*)]
DOI: 10.1021/acsnano.4c11172 SCOPUS: 85205766209